Science Explorer Back to mapMap
Discussion
Company · Seattle · ??

Cyrus Biotechnology

Research works
6
▲ 110% vs 2018-21
Citations
203
34.3 per fractional work
Top-10% rate
10.0%
all institutions 10.0%
Open access
92%
world 40%
International
10%
world 18%

Not ranked overall: Cyrus Biotechnology is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cyrus Biotechnology work in?

In all years, 53% of research at Cyrus Biotechnology is in Life Sciences, 41% in Health Sciences. Its largest fields are Medicine (41%), Biochemistry, Genetics and Molecular Biology (39%), Immunology and Microbiology (7%). It does 1.6× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 52.5% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 39.5% of its workMolecular Biology: 2 fractional works · 32.4% of its workBiotechnology: 0 fractional works · 2.9% of its workGenetics: 0 fractional works · 2.9% of its workStructural Biology: 0 fractional works · 1.4% of its workImmunology and Microbiology: 0 fractional works · 7.5% of its workMicrobiology: 0 fractional works · 5.6% of its workImmunology: 0 fractional works · 1.9% of its workNeuroscience: 0 fractional works · 5.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 5.6% of its workHealth Sciences: 2 fractional works · 41.4% of its workMedicine: 2 fractional works · 41.4% of its workPathology and Forensic Medicine: 1 fractional works · 16.9% of its workInfectious Diseases: 1 fractional works · 12.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 5.4% of its workEpidemiology: 0 fractional works · 3.4% of its workOncology: 0 fractional works · 1.9% of its workNeurology: 0 fractional works · 1.0% of its workPhysical Sciences: 0 fractional works · 5.6% of its workComputer Science: 0 fractional works · 3.6% of its workComputational Theory and Mathematics: 0 fractional works · 2.9% of its workComputer Science Applications: 0 fractional works · 0.3% of its workInformation Systems: 0 fractional works · 0.3% of its workComputer Networks and Communications: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 1.7% of its workMaterials Chemistry: 0 fractional works · 1.2% of its workSurfaces, Coatings and Films: 0 fractional works · 0.5% of its workChemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.5% of its workDecision Sciences: 0 fractional works · 0.5% of its workInformation Systems and Management: 0 fractional works · 0.5% of its workALL ITS WORKCyrusBiotechnology6fractional works, all years
Life Sciences53%Physical Sciences6%Health Sciences41%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology239.5%
    2. Immunology and Microbiology07.5%
    3. Neuroscience05.6%
    1. Medicine241.4%
    1. Computer Science03.6%
    2. Materials Science01.7%
    3. Chemistry00.3%
    1. Decision Sciences00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Cyrus Biotechnology?

The most cited paper from Cyrus Biotechnology is "Macromolecular modeling and design in Rosetta: recent methods and frameworks" (Julia Koehler Leman et al., 2020), with 954 citations. Next come "Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement" (342) and "Prediction of Protein Mutational Free Energy: Benchmark and Sampling Improvements Increase Classification Accuracy" (134).

Most cited papers
#PaperReleasedCitations
1 Macromolecular modeling and design in Rosetta: recent methods and frameworks Julia Koehler Leman et al. · Nature Methods Open access108 authors Jun 2020 954
2 Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement Frank DiMaio, Yifan Song, Xueming Li et al. · Nature Methods Open access 23 Feb 2015 342
3 Prediction of Protein Mutational Free Energy: Benchmark and Sampling Improvements Increase Classification Accuracy Brandon Frenz, Steven Macauley Lewis, Indigo King et al. · Frontiers in Bioengineering and Biotechnology Open access 8 Oct 2020 134
4 De novo design of a non-local β-sheet protein with high stability and accuracy Enrique Marcos, Tamuka M. Chidyausiku, Andrew C. McShan et al. · Nature Structural & Molecular Biology Open access 26 Oct 2018 134
5 Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants Lianghui Zhang, Soumajit Dutta, Shiqin Xiong et al. · Nature Chemical Biology Open access 19 Jan 2022 91
All 22 most cited papers, with filters and sorting

Which research topics does Cyrus Biotechnology publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, RNA and protein synthesis mechanisms, Chemical Synthesis and Analysis and Antimicrobial Peptides and Activities.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  2. 2 RNA and protein synthesis mechanisms Molecular Biology 0 works
  3. 3 Chemical Synthesis and Analysis Molecular Biology 0 works
  4. 4 Antimicrobial Peptides and Activities Microbiology 0 works
  5. 5 vaccines and immunoinformatics approaches Molecular Biology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  8. 8 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Glycosylation and Glycoproteins Research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available91.8%not open8.2%

World: 40% of research is openly available.

with international co-authors9.9%domestic only90.1%

World: 18% is written across borders.

How has Cyrus Biotechnology's research output changed?

Output in 2022-2025 was 110% higher than in 2018-2021.

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cyrus Biotechnology. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.